Fundraising FoxItalian Angels for Growth — 2021 Investments
4 investments dated 2021 · listed companies and verified rows first · show all
Cellply develops VivaCyte, an automated platform that combines microfluidic consumables, an instrument, and image-analysis software to characterize cell therapies at single-cell resolution.
AI & Machine LearningBiotechDeep TechHardwareMedical DevicesBologna, IT
Massimo Bocchi(Co-Founder & Chief Operating Officer)inAlessia Zanelli(President & CEO)inAndrea Faenza(Chief Technology Officer)in
Co-investorsIndaco Venture PartnersLIFTT
Cubbit provides distributed cloud storage infrastructure that combines on-premises and cloud technologies to give companies data sovereignty and cost control.
Cloud ComputingCybersecurityData & InfrastructureDeep TechIoTBologna, IT
Alessandro Cillario(Founder)inLorenzo Posani(Founder)Marco Moschettini(Founder)Stefano Onofri(Founder)
Co-investorsCDP Venture CapitalETF PartnersGrowth CapitalGrowth EngineLocalGlobeMoonstone Venture Capital+6 more
BiotechKennett Square, US
Frank Minella(Executive Officer, Director)inAlexander Ruckdaeschel(Executive Officer, Director)
BoardJohn H. Stewart(Director)Andrew Koopman(Director)
Co-investorsDelaware Crossing Investor GroupNYU Innovation Venture Fund
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
Arctic Bioscience AS
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.